Core Viewpoint - Guoxin Health (000503.SZ) reported a significant decline in revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved operating revenue of 95.53 million yuan, a year-on-year decrease of 30.47% [1] - The net profit attributable to shareholders was -99.09 million yuan [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -98.81 million yuan [1] - Basic earnings per share were -0.1012 yuan [1]

证券简称：国新健康 证券代码：000503 编号：2025-50 国新健康保障服务集团股份有限公司 第十二届监事会第三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 国新健康保障服务集团股份有限公司（以下简称"公司"）第十二届监事 会第三次会议于2025年8月15日发出会议通知，会议由监事会主席程志鹏先生召 集并主持，于2025年8月26日以现场结合通讯方式召开。本次会议应出席监事3 人，实际出席监事3人。会议的召开符合有关法律、行政法规、部门规章和《公 司章程》规定。 本次会议以记名投票方式表决，审议通过了如下议案： 一、公司 2025 年半年度报告及摘要 经审核，监事会认为董事会编制和审议公司2025年半年度报告的程序符合 法律、行政法规、中国证监会和深圳证券交易所的相关规定，报告内容能够真 实、准确、完整地反映上市公司的实际情况，不存在任何虚假记载、误导性陈 述或者重大遗漏。 表决情况：3票赞成、0票反对、0票弃权。 具体内容详见同日在《中国证券报》《上海证券报》《证券时报》及巨潮 资讯网（网址：www.cninfo.com.cn）披露的 ...

证券简称：国新健康 证券代码：000503 编号：2025-49 国新健康保障服务集团股份有限公司 表决结果：9票赞成，0票反对，0票弃权。 具体内容详见同日在巨潮资讯网（网址：www.cninfo.com.cn）披露的公司 《2025年半年度募集资金存放与使用情况专项报告》。 三、公司2025年半年度关于国新集团财务有限责任公司风险持续评估报告 第十二届董事会第三次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 国新健康保障服务集团股份有限公司（以下简称"公司"）第十二届董事 会第三次会议于2025年8月15日发出会议通知，会议由董事长李永华先生召集并 主持，于2025年8月26日以现场结合通讯方式召开。本次会议应出席董事9人， 实际出席董事9人，公司监事和高级管理人员列席会议。会议的召开符合有关法 律、行政法规、部门规章和《公司章程》规定。 本次会议以记名投票方式表决，审议通过了如下议案： 一、公司2025年半年度报告及摘要 表决情况：9票赞成，0票反对，0票弃权。 具体内容详见同日在《中国证券报》《上海证券报》《证券时报》及巨潮 资讯网（网 ...

国新健康公告，2025年上半年营业收入9553.01万元，同比下降30.47%。净亏损9909.07万元，上年同期 净亏损7298.15万元。公司计划不派发现金红利，不送红股，不以公积金转增股本。 ...

国新健康保障服务集团股份有限公司 2025 年半年度报告全文 国新健康保障服务集团股份有限公司 2025 年半年度报告 二零二五年八月 公司负责人袁洪泉、主管会计工作负责人王文长及会计机构负责人(会计 主管人员)张韬声明：保证本半年度报告中财务报告的真实、准确、完整。 所有董事均已出席了审议本次半年报的董事会会议。 国新健康保障服务集团股份有限公司 2025 年半年度报告全文 第一节 重要提示、目录和释义 公司董事会、监事会及董事、监事、高级管理人员保证半年度报告内容 的真实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担 个别和连带的法律责任。 公司在经营管理中可能面临的风险与应对措施已在本报告中第三节"管理 层讨论与分析"之"十、公司面临的风险和应对措施"部分予以描述。敬请 广大投资者关注，并注意投资风险。 公司计划不派发现金红利，不送红股，不以公积金转增股本。 1 | 第二节 | 公司简介和主要财务指标 5 | | --- | --- | | 第三节 | 管理层讨论与分析 8 | | 第四节 | 公司治理、环境和社会 27 | | 第五节 | 重要事项 29 | | 第六节 | 股份变动及股 ...

天眼查商业履历信息显示，国新健康保障服务集团股份有限公司，成立于1987年，位于青岛市，是一家 以从事研究和试验发展为主的企业。企业注册资本98417.6136万人民币，实缴资本98131.2532万人民 币。公司法定代表人为袁洪泉。 通过天眼查大数据分析，国新健康保障服务集团股份有限公司共对外投资了44家企业，参与招投标项目 22次，知识产权方面有商标信息54条，此外企业还拥有行政许可8个。 来源：金融界 金融界消息 截至2025年8月25日收盘，国新健康（000503）报收于11.18元，上涨0.36%，换手率 2.43%，成交量23.79万手，成交金额2.65亿元。 资金流向方面，今日主力资金净流出2341.32万元，占比成交额8.82%。其中，超大单净流入251.99万 元、占成交额0.95%，大单净流出2593.31万元、占成交额9.77%，中单净流出流入239.39万元、占成交 额0.9%，小单净流入2101.93万元、占成交额7.92%。 国新健康最新一期业绩显示，截至2025一季报，公司营业总收入5046.77万元、同比增长5.33%，归属净 利润4557.65万元，同比减少12.86%，扣非 ...

金融界消息 截至2025年8月13日收盘，国新健康（000503）报收于10.7元，上涨0.09%，换手率1.61%， 成交量15.80万手，成交金额1.69亿元。 资金流向方面，今日主力资金净流出1605.40万元，占比成交额9.5%。其中，超大单净流出1018.98万 元、占成交额6.03%，大单净流出586.42万元、占成交额3.47%，中单净流出流入376.84万元、占成交额 2.23%，小单净流入1228.57万元、占成交额7.27%。 国新健康最新一期业绩显示，截至2025一季报，公司营业总收入5046.77万元、同比增长5.33%，归属净 利润4557.65万元，同比减少12.86%，扣非净利润4556.85万元，同比减少12.45%，流动比率3.016、速动 比率3.013、资产负债率31.75%。 天眼查商业履历信息显示，国新健康保障服务集团股份有限公司，成立于1987年，位于青岛市，是一家 以从事研究和试验发展为主的企业。企业注册资本98417.6136万人民币，实缴资本98131.2532万人民 币。公司法定代表人为袁洪泉。 通过天眼查大数据分析，国新健康保障服务集团股份有限公司共对外投 ...

Core Insights - The stock price of Guo Xin Health (000503) closed at 10.75 yuan on August 11, 2025, reflecting a 1.42% increase with a turnover rate of 1.56% and a trading volume of 153,200 lots, amounting to 164 million yuan in transaction value [1] Financial Performance - For the first quarter of 2025, Guo Xin Health reported total operating revenue of 50.47 million yuan, representing a year-on-year growth of 5.33% [1] - The net profit attributable to shareholders was 45.58 million yuan, showing a year-on-year decrease of 12.86% [1] - The company's non-recurring net profit was 45.57 million yuan, down 12.45% year-on-year [1] - Key financial ratios include a current ratio of 3.016, a quick ratio of 3.013, and a debt-to-asset ratio of 31.75% [1] Investment and Business Activities - Guo Xin Health has made investments in 44 companies and participated in 22 bidding projects [2] - The company holds 54 trademark registrations and has obtained 8 administrative licenses [2] Company Background - Guo Xin Health was established in 1987 and is located in Qingdao, primarily engaged in research and experimental development [1] - The registered capital of the company is approximately 984.18 million yuan, with paid-in capital of about 981.31 million yuan [1]

Core Viewpoint - As of August 8, 2025, Guoxin Health's stock price closed at 10.60 yuan, reflecting a decrease of 0.40 yuan or 3.64% from the previous trading day [1] Group 1: Company Overview - Guoxin Health operates in sectors such as software development, AI pharmaceuticals, and data elements, focusing on healthcare big data services, medical insurance cost control, and pharmaceutical supply chain management [1] Group 2: Market Activity - On August 8, 2025, the trading volume for Guoxin Health was 302,478 hands, with a total transaction value of 324 million yuan [1] - The company has experienced a trend of capital outflow, with a net outflow of 10.82 million yuan on August 8 and a cumulative net outflow of 46.71 million yuan over the past five trading days [1]

Core Insights - The stock price of Guo Xin Health (000503) closed at 10.6 yuan on August 8, 2025, reflecting a decline of 3.64% with a turnover rate of 3.09% and a trading volume of 302,500 hands, amounting to 324 million yuan in transaction value [1] Financial Performance - For the first quarter of 2025, Guo Xin Health reported total operating revenue of 50.47 million yuan, representing a year-on-year growth of 5.33% [1] - The net profit attributable to shareholders was 45.58 million yuan, showing a year-on-year decrease of 12.86% [1] - The company's non-recurring net profit was 45.57 million yuan, also down by 12.45% year-on-year [1] - Key financial ratios include a current ratio of 3.016, a quick ratio of 3.013, and a debt-to-asset ratio of 31.75% [1] Capital Flow - On the trading day, the net outflow of main funds was 10.82 million yuan, accounting for 3.34% of the transaction value [1] - The breakdown of fund flows included a net outflow of 3.39 million yuan from large orders (1.05% of transaction value), 7.43 million yuan from big orders (2.29%), and a net inflow of 18.98 million yuan from medium orders (5.86%) [1] - Small orders experienced a net outflow of 8.16 million yuan, which is 2.52% of the transaction value [1] Company Background - Guo Xin Health was established in 1987 and is located in Qingdao, primarily engaged in research and experimental development [2] - The company has a registered capital of approximately 9.84 billion yuan and a paid-in capital of about 9.81 billion yuan [1] - The company has made investments in 44 enterprises and participated in 22 bidding projects, holding 54 trademark registrations and 8 administrative licenses [2]